Cargando…

Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts

BACKGROUND: Pompe disease (PD) is a metabolic myopathy caused by α-glucosidase (GAA) deficiency and characterized by generalized glycogen storage. Heterogeneous GAA gene mutations result in wide phenotypic variability, ranging from the severe classic infantile presentation to the milder intermediate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cardone, Monica, Porto, Caterina, Tarallo, Antonietta, Vicinanza, Mariella, Rossi, Barbara, Polishchuk, Elena, Donaudy, Francesca, Andria, Generoso, De Matteis, Maria Antonietta, Parenti, Giancarlo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635360/ https://www.ncbi.nlm.nih.gov/pubmed/19046416 http://dx.doi.org/10.1186/1755-8417-1-6

Ejemplares similares

The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts
por: Porto, Caterina, et al.
Publicado: (2009)

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
por: Tarallo, Antonietta, et al.
Publicado: (2021)

S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011)

S1.2 The pediatrician and the early onset Pompe disease
por: Fecarotta, Simona, et al.
Publicado: (2011)

Function and dysfunction of the PI system in membrane trafficking
por: Vicinanza, Mariella, et al.
Publicado: (2008)

Carnitine is a pharmacological allosteric chaperone of the human lysosomal α-glucosidase
por: Iacono, Roberta, et al.
Publicado: (2021)

AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
por: Gatto, Francesca, et al.
Publicado: (2017)

Improvement of dysphagia in a child affected by Pompe disease treated with enzyme replacement therapy
por: Fecarotta, Simona, et al.
Publicado: (2013)

Satellite cells maintain regenerative capacity but fail to repair disease-associated muscle damage in mice with Pompe disease
por: Schaaf, Gerben J., et al.
Publicado: (2018)

Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
por: Roig-Zamboni, Véronique, et al.
Publicado: (2017)

Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
por: Spampanato, Carmine, et al.
Publicado: (2013)

Pathogenesis of Mucopolysaccharidoses, an Update
por: Fecarotta, Simona, et al.
Publicado: (2020)

Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases
por: Belfiore, Maria Paola, et al.
Publicado: (2020)

A determinant in the cytoplasmic tail of the cation-dependent mannose 6- phosphate receptor prevents trafficking to lysosomes
Publicado: (1995)

Mannose 6‐phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease
por: Godefroy, Anastasia, et al.
Publicado: (2019)

From Acid Alpha-Glucosidase Deficiency to Autophagy: Understanding the Bases of POMPE Disease
por: Sánchez-Porras, Valentina, et al.
Publicado: (2023)

AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice
por: Meena, Naresh K., et al.
Publicado: (2023)

A Role of Rab29 in the Integrity of the Trans-Golgi Network and Retrograde Trafficking of Mannose-6-Phosphate Receptor
por: Wang, Shicong, et al.
Publicado: (2014)

Respiratory manifestations in patients with inherited metabolic diseases
por: Santamaria, Francesca, et al.
Publicado: (2013)

Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase
por: Cagin, Umut, et al.
Publicado: (2020)

Postbiotic Preparation of Lacticaseibacillus rhamnosus GG against Diarrhea and Oxidative Stress Induced by Spike Protein of SARS-CoV-2 in Human Enterocytes
por: Poeta, Marco, et al.
Publicado: (2023)

Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe Disease
por: Gal, Aniko, et al.
Publicado: (2021)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation
por: Calcagni’, Alessia, et al.
Publicado: (2023)

The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease
por: Khanna, Richie, et al.
Publicado: (2012)

A Nonsense Mutation in the Acid α-Glucosidase Gene Causes Pompe Disease in Finnish and Swedish Lapphunds
por: Seppälä, Eija H., et al.
Publicado: (2013)

Glycosylation-independent Lysosomal Targeting of Acid α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice
por: Maga, John A., et al.
Publicado: (2013)

Tissue plasminogen activator is a ligand of cation-independent mannose 6-phosphate receptor and consists of glycoforms that contain mannose 6-phosphate
por: Miller, James J., et al.
Publicado: (2021)

Glucosidase II and N-glycan mannose content regulate the half-lives of monoglucosylated species in vivo
por: Stigliano, Ivan D., et al.
Publicado: (2011)

Involvement of endocrine system in a patient affected by Glycogen storage disease 1b: speculation on the role of autoimmunity
por: Melis, Daniela, et al.
Publicado: (2014)

Gold Nanoparticles Decorated with Mannose-6-phosphate Analogues
por: Combemale, Stéphanie, et al.
Publicado: (2014)

Cysteine34 of the cytoplasmic tail of the cation-dependent mannose 6- phosphate receptor is reversibly palmitoylated and required for normal trafficking and lysosomal enzyme sorting
Publicado: (1996)

Three years experience with dried blood spot α-glucosidase screening for Pompe disease in British Columbia, Canada
por: Horvath, Gabriella, et al.
Publicado: (2013)

Molecular Diagnosis of Pompe Disease in the Genomic Era: Correlation with Acid Alpha-Glucosidase Activity in Dried Blood Spots
por: Thuriot, Fanny, et al.
Publicado: (2021)

Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease
por: Liang, Qiushi, et al.
Publicado: (2022)

Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy
por: Noman, Kinza, et al.
Publicado: (2020)

Lysosomal enzyme trafficking in mannose 6-phosphate receptor-positive mouse L-cells: demonstration of a steady state accumulation of phosphorylated acid hydrolases
Publicado: (1986)

Redistribution of mannose-6-phosphate receptors induced by tunicamycin and chloroquine
Publicado: (1984)

Differences in the endosomal distributions of the two mannose 6- phosphate receptors
Publicado: (1993)

Ultrastructural localization of the mannose 6-phosphate receptor in rat liver
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_09oor1ncls9tchh5i4hi5f3023